Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer

PURPOSE: Citrate synthase (CS) is a rate-limiting enzyme in the citrate cycle and is capable of catalyzing oxaloacetate and acetyl-CoA to citrate. CS has been uncovered to be upregulated in a variety of cancers, and its expression and clinical significance in prostate cancer (PCa) remain unknown. ME...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cancer Manag Res
Główni autorzy: Cai, Zhiduan, Deng, Yulin, Ye, Jianheng, Zhuo, Yangjia, Liu, Zezhen, Liang, Yingke, Zhang, Hui, Zhu, Xuejin, Luo, Yong, Feng, Yuanfa, Liu, Ren, Chen, Guo, Wu, Yongding, Han, Zhaodong, Liang, Yuxiang, Jiang, Funeng, Zhong, Weide
Format: Artigo
Język:Inglês
Wydane: Dove 2020
Hasła przedmiotowe:
Original Research
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7398875/
https://ncbi.nlm.nih.gov/pubmed/32801864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S255817
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy